Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 12JANSSEN BIOTECH

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
IMCAS Asia
Not Confirmed
arrow
IMCAS Asia
Not Confirmed

LAZERTINIB MESYLATE

US Patent Number : 9593098

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 219008

Patent Use Code : U-3985

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-10-13

blank

02

arrow
IMCAS Asia
Not Confirmed
arrow
IMCAS Asia
Not Confirmed

LAZERTINIB MESYLATE

US Patent Number : 9593098

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 219008

Patent Use Code : U-3985

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-10-13

blank

03

arrow
IMCAS Asia
Not Confirmed
arrow
IMCAS Asia
Not Confirmed

LAZERTINIB MESYLATE

US Patent Number : 11981659

Drug Substance Claim :

Drug Product Claim :

Application Number : 219008

Patent Use Code : U-3985

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-04-18

blank

04

arrow
IMCAS Asia
Not Confirmed
arrow
IMCAS Asia
Not Confirmed

LAZERTINIB MESYLATE

US Patent Number : 11981659

Drug Substance Claim :

Drug Product Claim :

Application Number : 219008

Patent Use Code : U-3985

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-04-18

blank

05

arrow
IMCAS Asia
Not Confirmed
arrow
IMCAS Asia
Not Confirmed

LAZERTINIB MESYLATE

US Patent Number : 11850248

Drug Substance Claim :

Drug Product Claim :

Application Number : 219008

Patent Use Code : U-3985

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-08-01

blank

06

arrow
IMCAS Asia
Not Confirmed
arrow
IMCAS Asia
Not Confirmed

LAZERTINIB MESYLATE

US Patent Number : 11850248

Drug Substance Claim :

Drug Product Claim :

Application Number : 219008

Patent Use Code : U-3985

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-08-01

blank

07

arrow
IMCAS Asia
Not Confirmed
arrow
IMCAS Asia
Not Confirmed

LAZERTINIB MESYLATE

US Patent Number : 11879013

Drug Substance Claim :

Drug Product Claim :

Application Number : 219008

Patent Use Code : U-3985

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-05-21

blank

08

arrow
IMCAS Asia
Not Confirmed
arrow
IMCAS Asia
Not Confirmed

LAZERTINIB MESYLATE

US Patent Number : 11879013

Drug Substance Claim :

Drug Product Claim :

Application Number : 219008

Patent Use Code : U-3985

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-05-21

blank

09

arrow
IMCAS Asia
Not Confirmed
arrow
IMCAS Asia
Not Confirmed

LAZERTINIB MESYLATE

US Patent Number : 11453656

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 219008

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-04-18

blank

10

arrow
IMCAS Asia
Not Confirmed
arrow
IMCAS Asia
Not Confirmed

LAZERTINIB MESYLATE

US Patent Number : 12138351

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 219008

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-04-13

blank